Research

Hormonal

Daily oral administration of live Dysosmobacter welbionis J115T (1.0×10^9 CFU) prevents diet-induced obesity, reduces fat mass gain, and improves glucose tolerance in mice fed a high-fat diet.

In a mouse model, daily consumption of live Dysosmobacter welbionis J115T at a dose of 1 billion colony-forming units prevented weight gain and improved metabolic health during a high-fat diet. This effect was specific to live bacteria, as pasteurized versions were ineffective. This suggests that maintaining bacterial viability is critical for this specific strain's metabolic benefits.

ModerateSupportsMEDIUM confidence
gavaging high-fat diet (HFD)- fed mice with daily and freshly prepared live D. welbionis J115T (1.0×109 cultivable, live bacteria per day and per mouse) for 6 weeks (HFD J115- fresh group) decreased the HFD- induced weight gain by 29% (ie, 1.5 grams)
Tiphaine Le Roy et al. · Gut · 2021

Why this rating

Strong preclinical evidence in mice with clear mechanistic pathways, but lacks human clinical trial data.

Source

<i>Dysosmobacter welbionis</i> is a newly isolated human commensal bacterium preventing diet-induced obesity and metabolic disorders in mice

Tiphaine Le Roy et al. · Gut · 2021

DOI 10.1136/gutjnl-2020-323778

mechanism_only · n=11984Cited 220×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →